《药剂学15周年——工艺与制剂建模进展》
15th Anniversary of Pharmaceutics-Advances in Process and Formulation Modeling.
作者信息
Bilgili Ecevit, Poozesh Sadegh
机构信息
Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Mechanical Engineering Department, Tuskegee University, Tuskegee, AL 36088, USA.
出版信息
Pharmaceutics. 2024 Aug 11;16(8):1056. doi: 10.3390/pharmaceutics16081056.
Abstract
The modeling of processes and formulations significantly enhances product development in the pharmaceutical industry [...].
摘要
工艺和配方的建模显著提升了制药行业的产品开发水平[……]。
相似文献
1
15th Anniversary of Pharmaceutics-Advances in Process and Formulation Modeling.《药剂学15周年——工艺与制剂建模进展》
Pharmaceutics. 2024 Aug 11;16(8):1056. doi: 10.3390/pharmaceutics16081056.
2
Computational pharmaceutics - A new paradigm of drug delivery.计算药剂学——药物传递的新模式。
J Control Release. 2021 Oct 10;338:119-136. doi: 10.1016/j.jconrel.2021.08.030. Epub 2021 Aug 19.
3
Promises of Molecular Pharmaceutics in the Development of Novel Drug Delivery Formulations.分子药剂学在新型药物传递制剂开发中的应用前景。
Curr Drug Deliv. 2023;20(9):1262-1274. doi: 10.2174/1567201820666221114113637.
4
How can machine learning and multiscale modeling benefit ocular drug development?机器学习和多尺度建模如何助力眼科药物研发？
Adv Drug Deliv Rev. 2023 May;196:114772. doi: 10.1016/j.addr.2023.114772. Epub 2023 Mar 10.
5
Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges.杀微生物剂制剂的开发药剂学。第二部分：制剂、评价及挑战。
AIDS Patient Care STDS. 2003 Aug;17(8):377-99. doi: 10.1089/108729103322277402.
6
Modeling and Simulation of Process Technology for Nanoparticulate Drug Formulations-A Particle Technology Perspective.纳米颗粒药物制剂工艺技术的建模与仿真——颗粒技术视角
Pharmaceutics. 2020 Dec 24;13(1):22. doi: 10.3390/pharmaceutics13010022.
7
State-of-the-Art Review of Artificial Neural Networks to Predict, Characterize and Optimize Pharmaceutical Formulation.用于预测、表征和优化药物制剂的人工神经网络的最新综述
Pharmaceutics. 2022 Jan 13;14(1):183. doi: 10.3390/pharmaceutics14010183.
8
Opportunities for pharmacists as managers: perceptions of senior executives in the pharmaceutical industry.药剂师作为管理者的机遇：制药行业高级管理人员的看法。
J Am Pharm Assoc (Wash). 1999 Jan-Feb;39(1):41-4. doi: 10.1016/s1086-5802(16)30414-4.
9
First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing.基于第一性原理和经验方法预测药物制剂和工艺开发以及产品释放测试中的体外溶出度。
AAPS J. 2019 Feb 21;21(3):32. doi: 10.1208/s12248-019-0297-y.
10
Formulation design space: a proven approach to maximize flexibility and outcomes within early clinical development.制剂设计空间：在早期临床开发中最大化灵活性和成果的经证实方法。
Ther Deliv. 2015;6(11):1269-78. doi: 10.4155/tde.15.76. Epub 2015 Nov 24.
本文引用的文献
1
Pharmaceutical Process Modeling.制药过程建模
AAPS PharmSciTech. 2022 Mar 16;23(4):91. doi: 10.1208/s12249-022-02246-4.
2
Pharmaceutical nanocrystals: production by wet milling and applications.药物纳米晶体：湿磨法生产及应用。
Drug Discov Today. 2018 Mar;23(3):534-547. doi: 10.1016/j.drudis.2018.01.016. Epub 2018 Jan 8.
3
A brief literature and patent review of nanosuspensions to a final drug product.纳米混悬液到最终药品的简要文献及专利综述。
J Pharm Sci. 2014 Oct;103(10):2980-99. doi: 10.1002/jps.24098. Epub 2014 Aug 6.
4
Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size.不同粒径的肌内注射长效棕榈酸帕利哌酮纳米混悬液的研制与比较。
Int J Pharm. 2014 Sep 10;472(1-2):380-5. doi: 10.1016/j.ijpharm.2014.05.052. Epub 2014 Jun 2.
5
Nanosizing--oral formulation development and biopharmaceutical evaluation.纳米尺寸——口服制剂研发与生物药剂学评价
Adv Drug Deliv Rev. 2007 Jul 30;59(7):631-44. doi: 10.1016/j.addr.2007.05.003. Epub 2007 May 25.
Zotero 插件